Granules India Ltd
Granules India is primarily engaged in the business of manufacturing and selling of Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation intermediates (PFIs) and Finished Dosages (FDs).(Source : 202003-01 Annual Report Page No:109)
- Market Cap ₹ 8,328 Cr.
- Current Price ₹ 336
- High / Low ₹ 438 / 114
- Stock P/E 17.6
- Book Value ₹ 77.1
- Dividend Yield 0.30 %
- ROCE 17.2 %
- ROE 18.7 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company has delivered good profit growth of 28.22% CAGR over last 5 years
- Company's median sales growth is 16.43% of last 10 years
Cons
- Stock is trading at 4.36 times its book value
- Company might be capitalizing the interest cost
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
504 | 453 | 581 | 632 | 613 | 595 | 700 | 704 | 600 | 736 | 858 | 845 | |
460 | 381 | 480 | 518 | 516 | 477 | 556 | 541 | 500 | 552 | 602 | 633 | |
Operating Profit | 44 | 73 | 101 | 113 | 98 | 119 | 144 | 163 | 100 | 184 | 256 | 212 |
OPM % | 9% | 16% | 17% | 18% | 16% | 20% | 21% | 23% | 17% | 25% | 30% | 25% |
Other Income | 13 | 29 | 17 | 8 | 21 | 27 | 9 | -29 | 82 | 6 | 3 | 16 |
Interest | 6 | 7 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 7 |
Depreciation | 20 | 25 | 27 | 27 | 27 | 29 | 30 | 39 | 39 | 34 | 36 | 37 |
Profit before tax | 30 | 71 | 84 | 87 | 84 | 110 | 115 | 89 | 137 | 149 | 217 | 184 |
Tax % | 32% | 27% | 28% | 30% | 24% | 25% | 17% | 28% | 32% | 25% | 25% | 20% |
Net Profit | 20 | 52 | 60 | 60 | 64 | 83 | 96 | 64 | 92 | 111 | 164 | 147 |
EPS in Rs | 0.81 | 2.04 | 2.37 | 2.37 | 2.52 | 3.27 | 3.77 | 2.52 | 3.63 | 4.51 | 6.61 | 5.93 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
289 | 460 | 475 | 654 | 761 | 1,084 | 1,292 | 1,357 | 1,411 | 1,685 | 2,279 | 2,599 | 3,038 | |
256 | 399 | 418 | 575 | 676 | 925 | 1,082 | 1,081 | 1,112 | 1,406 | 1,895 | 2,073 | 2,287 | |
Operating Profit | 33 | 61 | 57 | 79 | 86 | 159 | 210 | 276 | 299 | 278 | 384 | 525 | 752 |
OPM % | 11% | 13% | 12% | 12% | 11% | 15% | 16% | 20% | 21% | 17% | 17% | 20% | 25% |
Other Income | 1 | 13 | 0 | 1 | 1 | 4 | 3 | 5 | 35 | 27 | 75 | 90 | 108 |
Interest | 16 | 18 | 12 | 17 | 18 | 20 | 32 | 37 | 32 | 33 | 28 | 27 | 26 |
Depreciation | 12 | 19 | 18 | 21 | 23 | 30 | 53 | 58 | 72 | 76 | 105 | 137 | 146 |
Profit before tax | 7 | 38 | 27 | 43 | 46 | 112 | 128 | 186 | 230 | 196 | 326 | 451 | 687 |
Tax % | 39% | 19% | 22% | 30% | 30% | 33% | 29% | 33% | 28% | 32% | 27% | 26% | |
Net Profit | 4 | 30 | 21 | 30 | 33 | 75 | 91 | 123 | 165 | 133 | 236 | 335 | 514 |
EPS in Rs | 0.21 | 1.51 | 1.04 | 1.49 | 1.62 | 3.71 | 4.45 | 5.68 | 7.19 | 5.22 | 9.30 | 13.19 | 20.68 |
Dividend Payout % | 64% | 9% | 14% | 13% | 12% | 9% | 11% | 11% | 13% | 19% | 11% | 8% |
Compounded Sales Growth | |
---|---|
10 Years: | 19% |
5 Years: | 15% |
3 Years: | 23% |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | 26% |
5 Years: | 28% |
3 Years: | 24% |
TTM: | 45% |
Stock Price CAGR | |
---|---|
10 Years: | 43% |
5 Years: | 23% |
3 Years: | 43% |
1 Year: | 103% |
Return on Equity | |
---|---|
10 Years: | 18% |
5 Years: | 18% |
3 Years: | 16% |
Last Year: | 19% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
22 | 22 | 20 | 20 | 20 | 20 | 20 | 22 | 23 | 25 | 25 | 25 | 25 | |
Reserves | 153 | 181 | 200 | 225 | 254 | 335 | 411 | 640 | 881 | 1,279 | 1,504 | 1,818 | 1,884 |
Borrowings | 183 | 147 | 121 | 204 | 270 | 442 | 482 | 641 | 656 | 978 | 991 | 892 | 772 |
46 | 66 | 95 | 123 | 138 | 195 | 289 | 260 | 319 | 388 | 458 | 560 | 808 | |
Total Liabilities | 405 | 415 | 436 | 571 | 683 | 992 | 1,203 | 1,563 | 1,879 | 2,670 | 2,979 | 3,296 | 3,488 |
243 | 237 | 239 | 250 | 263 | 482 | 617 | 560 | 644 | 777 | 944 | 1,204 | 1,400 | |
CWIP | 2 | 2 | 7 | 29 | 109 | 125 | 62 | 77 | 267 | 515 | 496 | 294 | 108 |
Investments | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 70 | 108 | 157 | 210 | 19 | 19 |
159 | 176 | 190 | 291 | 301 | 385 | 524 | 856 | 859 | 1,222 | 1,328 | 1,779 | 1,961 | |
Total Assets | 405 | 415 | 436 | 571 | 683 | 992 | 1,203 | 1,563 | 1,879 | 2,670 | 2,979 | 3,296 | 3,488 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-28 | 60 | 49 | 26 | 91 | 108 | 150 | 151 | 188 | -1 | 262 | 476 | |
-9 | -13 | -25 | -54 | -128 | -255 | -146 | -162 | -326 | -462 | -270 | -160 | |
39 | -46 | -25 | 49 | 46 | 147 | 19 | 86 | 56 | 529 | -17 | -213 | |
Net Cash Flow | 2 | 1 | -1 | 20 | 10 | 0 | 24 | 75 | -82 | 66 | -25 | 103 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 16% | 11% | 15% | 13% | 20% | 19% | 20% | 18% | 12% | 15% | 17% | |
Debtor Days | 80 | 52 | 55 | 53 | 34 | 37 | 39 | 101 | 108 | 136 | 108 | 103 |
Inventory Turnover | 4.76 | 4.38 | 4.76 | 4.10 | 4.39 | 3.98 | 3.18 | 2.75 | 3.44 | 3.95 | 3.26 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Press Release / Media Release 24 Feb
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 22 Feb
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 18 Feb
- Announcement under Regulation 30 (LODR)-Press Release / Media Release 17 Feb
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Feb
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2010 from bse
- Financial Year 2010 from nse
- Financial Year 2009 from nse